Tokyo Tape
Sign in
← CellSeed

Quarterly report · Q2

7776.TEDINET S100RMQI
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥67m2023-01-01 → 2023-06-30StandaloneNet sales
Revenue¥126m2022-01-01 → 2022-12-31StandaloneNet sales (5-year summary)
Revenue¥75m2022-01-01 → 2022-06-30StandaloneNet sales
Operating income−¥359m2023-01-01 → 2023-06-30StandaloneOperating income
Operating income−¥349m2022-01-01 → 2022-06-30StandaloneOperating income
Ordinary income−¥367m2023-01-01 → 2023-06-30StandaloneOrdinary income
Ordinary income−¥754m2022-01-01 → 2022-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥353m2022-01-01 → 2022-06-30StandaloneOrdinary income
Profit before tax−¥363m2023-01-01 → 2023-06-30StandaloneIncome before income taxes
Profit before tax−¥355m2022-01-01 → 2022-06-30StandaloneIncome before income taxes
Net income−¥364m2023-01-01 → 2023-06-30StandaloneProfit loss
Net income−¥760m2022-01-01 → 2022-12-31StandaloneNet income loss (5-year summary)
Net income−¥357m2022-01-01 → 2022-06-30StandaloneProfit loss
Total assets¥2.0bnat 2023-06-30StandaloneAssets
Total assets¥1.5bnat 2022-12-31StandaloneAssets
Total assets¥1.7bnat 2022-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥363mat 2023-06-30StandaloneLiabilities
Total liabilities¥366mat 2022-12-31StandaloneLiabilities
Net assets / equity¥1.7bnat 2023-06-30StandaloneNet assets
Net assets / equity¥1.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.3bnat 2022-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.6bnat 2023-06-30StandaloneCash and deposits
Cash and deposits¥1.1bnat 2022-12-31StandaloneCash and deposits
Cash & equivalents¥1.6bnat 2023-06-30StandaloneCash and cash equivalents
Cash & equivalents¥1.1bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥1.2bnat 2022-06-30StandaloneCash and cash equivalents
Cash & equivalents¥847mat 2021-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥348m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥718m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥269m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥18m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥62m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥15m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥848m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥882m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥606m2022-01-01 → 2022-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-13.292023-01-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.492023-04-01 → 2023-06-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-36.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-18.542022-01-01 → 2022-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-7.752022-04-01 → 2022-06-30dStandaloneBasic earnings loss per share (5-year summary)
Equity ratio81.1%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio74.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio75.1%at 2022-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued28,385,419at 2023-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued24,422,619at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued22,159,419at 2022-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 20
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥96m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2023-01-01 → 2023-06-30¥5m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2023-01-01 → 2023-06-30¥5m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2023-01-01 → 2023-06-30−¥236m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2023-01-01 → 2023-06-30¥62m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2023-01-01 → 2023-06-30¥62m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2023-01-01 → 2023-06-30−¥28m
—segment totalrevenue2023-01-01 → 2023-06-30¥67m
—segment totalrevenue external2023-01-01 → 2023-06-30¥67m
—segment totalsegment profit2023-01-01 → 2023-06-30−¥263m
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-06-30−¥100m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue2022-01-01 → 2022-06-30¥4m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentrevenue external2022-01-01 → 2022-06-30¥4m
jpcrp040300-q2r_E24158-000Cell Sheet Regenerative Medicinereportable segmentsegment profit2022-01-01 → 2022-06-30−¥208m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue2022-01-01 → 2022-06-30¥70m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentrevenue external2022-01-01 → 2022-06-30¥70m
jpcrp040300-q2r_E24158-000Laboratory Consumable Equipmentreportable segmentsegment profit2022-01-01 → 2022-06-30−¥41m
—segment totalrevenue2022-01-01 → 2022-06-30¥75m
—segment totalrevenue external2022-01-01 → 2022-06-30¥75m
—segment totalsegment profit2022-01-01 → 2022-06-30−¥248m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 443
ItemContextValueUnit
Net salesPrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E24158-000CellSheetRegenerativeMedicineReportableSegmentsMember4424000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember74612000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesPrior1YTDDuration_NonConsolidatedMember74612000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E24158-000LaboratoryConsumableEquipmentReportableSegmentsMember-40545000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E24158-000CellSheetRegenerativeMedicineReportableSegmentsMember-207874000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReportableSegmentsMember-248419000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember_ReconcilingItemsMember-100424000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-348844000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E24158-000LaboratoryConsumableEquipmentReportableSegmentsMember62018000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E24158-000CellSheetRegenerativeMedicineReportableSegmentsMember4947000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember66966000JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration_NonConsolidatedMember66966000JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E24158-000LaboratoryConsumableEquipmentReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E24158-000CellSheetRegenerativeMedicineReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Transactions with other segmentsCurrentYTDDuration_NonConsolidatedMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E24158-000LaboratoryConsumableEquipmentReportableSegmentsMember62018000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E24158-000CellSheetRegenerativeMedicineReportableSegmentsMember4947000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember66966000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember－JPY
Net salesCurrentYTDDuration_NonConsolidatedMember66966000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E24158-000LaboratoryConsumableEquipmentReportableSegmentsMember-27663000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_jpcrp040300-q2r_E24158-000CellSheetRegenerativeMedicineReportableSegmentsMember-235584000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReportableSegmentsMember-263248000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember_ReconcilingItemsMember-95966000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-359215000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-08-14
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第23期第２四半期（自　2023年４月１日　至　2023年６月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社セルシード
Company name in english cover pageFilingDateInstantCellSeed Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　橋本　せつ子
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都江東区青海二丁目５番10号テレコムセンタービル
Telephone number address of registered headquarter cover pageFilingDateInstant03-6380-7490
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)経営管理部長　畑中　格
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都江東区青海二丁目５番10号テレコムセンタービル
Telephone number nearest place of contact cover pageFilingDateInstant03-6380-7490
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)経営管理部長　畑中　格
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE24158
Fund codeFilingDateInstant－
Security codeFilingDateInstant77760
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社セルシード
Filer name in englishFilingDateInstantCellSeed Inc.
Fund name in japaneseFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2022-12-31pass
balance sheet identitynon_consolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-06-30pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-06-30pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · total assetsnon_consolidated 2022-12-31pass
statement vs summary · total assetsnon_consolidated 2023-06-30pass